177 related articles for article (PubMed ID: 23572014)
1. Decreasing excess mortality of HIV-infected patients initiating antiretroviral therapy: comparison with mortality in general population in China, 2003-2009.
Zhu H; Napravnik S; Eron JJ; Cole SR; Ma Y; Wohl DA; Dou Z; Zhang Y; Liu Z; Zhao D; Yu L; Liu X; Cohen MS; Zhang F
J Acquir Immune Defic Syndr; 2013 Aug; 63(5):e150-7. PubMed ID: 23572014
[TBL] [Abstract][Full Text] [Related]
2. Excess mortality and associated factors among people living with HIV initiating highly active antiretroviral therapy in Luzhou, China 2006-2020.
Niu D; Xiao T; Chen Y; Tang H; Chen F; Cai C; Qin Q; Zhao D; Jin Y; Wang S; Hou Y; Lu Z; Yang L; Liu H; Xie D; Zou H; Lyu F
BMC Infect Dis; 2023 Mar; 23(1):186. PubMed ID: 36991355
[TBL] [Abstract][Full Text] [Related]
3. Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the french hospital database on HIV.
Piketty C; Selinger-Leneman H; Bouvier AM; Belot A; Mary-Krause M; Duvivier C; Bonmarchand M; Abramowitz L; Costagliola D; Grabar S
J Clin Oncol; 2012 Dec; 30(35):4360-6. PubMed ID: 23091098
[TBL] [Abstract][Full Text] [Related]
4. Attrition among human immunodeficiency virus (HIV)- infected patients initiating antiretroviral therapy in China, 2003-2010.
Zhu H; Napravnik S; Eron J; Cole S; Ma Y; Wohl D; Dou Z; Zhang Y; Liu Z; Zhao D; Cohen M; Zhang F
PLoS One; 2012; 7(6):e39414. PubMed ID: 22761787
[TBL] [Abstract][Full Text] [Related]
5. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis.
Teeraananchai S; Kerr SJ; Amin J; Ruxrungtham K; Law MG
HIV Med; 2017 Apr; 18(4):256-266. PubMed ID: 27578404
[TBL] [Abstract][Full Text] [Related]
6. Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China.
Liao L; Xing H; Su B; Wang Z; Ruan Y; Wang X; Liu Z; Lu Y; Yang S; Zhao Q; Vermund SH; Chen RY; Shao Y
AIDS; 2013 Jul; 27(11):1815-24. PubMed ID: 23803794
[TBL] [Abstract][Full Text] [Related]
7. A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression.
Loutfy MR; Genebat M; Moore D; Raboud J; Chan K; Antoniou T; Milan D; Shen A; Klein MB; Cooper C; Machouf N; Rourke SB; Rachlis A; Tsoukas C; Montaner JS; Walmsley SL; Smieja M; Bayoumi A; Mills E; Hogg RS;
J Acquir Immune Defic Syndr; 2010 Dec; 55(4):451-9. PubMed ID: 21105259
[TBL] [Abstract][Full Text] [Related]
8. Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort.
Grabar S; Tattevin P; Selinger-Leneman H; de La Blanchardiere A; de Truchis P; Rabaud C; Rey D; Daneluzzi V; Ferret S; Lascaux AS; Hanslik T; Costagliola D; Launay O;
Clin Infect Dis; 2015 Apr; 60(8):1269-77. PubMed ID: 25601456
[TBL] [Abstract][Full Text] [Related]
9. Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017.
Ruffieux Y; Lemsalu L; Aebi-Popp K; Calmy A; Cavassini M; Fux CA; Günthard HF; Marzolini C; Scherrer A; Vernazza P; Keiser O; Egger M;
J Int AIDS Soc; 2019 Aug; 22(8):e25339. PubMed ID: 31423727
[TBL] [Abstract][Full Text] [Related]
10. Changing Incidence and Risk Factors for Kaposi Sarcoma by Time Since Starting Antiretroviral Therapy: Collaborative Analysis of 21 European Cohort Studies.
Cancer Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord
Clin Infect Dis; 2016 Nov; 63(10):1373-1379. PubMed ID: 27535953
[TBL] [Abstract][Full Text] [Related]
11. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study.
Zhang F; Dou Z; Ma Y; Zhang Y; Zhao Y; Zhao D; Zhou S; Bulterys M; Zhu H; Chen RY
Lancet Infect Dis; 2011 Jul; 11(7):516-24. PubMed ID: 21600849
[TBL] [Abstract][Full Text] [Related]
12. Changes in the risk of death after HIV seroconversion compared with mortality in the general population.
Bhaskaran K; Hamouda O; Sannes M; Boufassa F; Johnson AM; Lambert PC; Porter K;
JAMA; 2008 Jul; 300(1):51-9. PubMed ID: 18594040
[TBL] [Abstract][Full Text] [Related]
13. Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral Therapy.
Mirani G; Williams PL; Chernoff M; Abzug MJ; Levin MJ; Seage GR; Oleske JM; Purswani MU; Hazra R; Traite S; Zimmer B; Van Dyke RB;
Clin Infect Dis; 2015 Dec; 61(12):1850-61. PubMed ID: 26270680
[TBL] [Abstract][Full Text] [Related]
14. Risk factors affecting the mortality of HIV-infected patients with pulmonary tuberculosis in the cART era: a retrospective cohort study in China.
Ji YJ; Liang PP; Shen JY; Sun JJ; Yang JY; Chen J; Qi TK; Wang ZY; Song W; Tang Y; Liu L; Zhang RF; Shen YZ; Lu HZ
Infect Dis Poverty; 2018 Mar; 7(1):25. PubMed ID: 29587840
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy.
McManus H; O'Connor CC; Boyd M; Broom J; Russell D; Watson K; Roth N; Read PJ; Petoumenos K; Law MG;
PLoS One; 2012; 7(11):e48839. PubMed ID: 23144991
[TBL] [Abstract][Full Text] [Related]
16. Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population.
Gueler A; Moser A; Calmy A; Günthard HF; Bernasconi E; Furrer H; Fux CA; Battegay M; Cavassini M; Vernazza P; Zwahlen M; Egger M;
AIDS; 2017 Jan; 31(3):427-436. PubMed ID: 27831953
[TBL] [Abstract][Full Text] [Related]
17. Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality.
Brinkhof MW; Boulle A; Weigel R; Messou E; Mathers C; Orrell C; Dabis F; Pascoe M; Egger M;
PLoS Med; 2009 Apr; 6(4):e1000066. PubMed ID: 19399157
[TBL] [Abstract][Full Text] [Related]
18. Course and Clinical Significance of CD8+ T-Cell Counts in a Large Cohort of HIV-Infected Individuals.
Helleberg M; Kronborg G; Ullum H; Ryder LP; Obel N; Gerstoft J
J Infect Dis; 2015 Jun; 211(11):1726-34. PubMed ID: 25489001
[TBL] [Abstract][Full Text] [Related]
19. Fibrosis-4 index predicts mortality in HIV/HCV co-infected patients receiving combination antiretroviral therapy in rural China.
Chen X; Liu X; Tang R; Ye R; Yang Y; Yao S; Wang J; Ding Y; Duan S; He N
Biosci Trends; 2019 Mar; 13(1):32-39. PubMed ID: 30726798
[TBL] [Abstract][Full Text] [Related]
20. HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population.
Lewden C; Chene G; Morlat P; Raffi F; Dupon M; Dellamonica P; Pellegrin JL; Katlama C; Dabis F; Leport C; ;
J Acquir Immune Defic Syndr; 2007 Sep; 46(1):72-7. PubMed ID: 17621240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
